Showing results for 
Search instead for 
Did you mean: 

Therapeutic Drug Research of 8 New Anticancer Agents by LC-MS/MS

Scientific Advocate II
Scientific Advocate II
The treatment of some cancers has shifted from conventional chemotherapy drugs to chronic treatment with molecular targeted therapies. Targeted therapies include drugs such as Tyrosine kinase inhibitors (eg: Imatinib, Dasatinib, Nilotinib, Sunitinib,
Sorafenib, Vandetanib, Lapatinib, Vatalanib and Erlotinib) that present better efficiency and lower side effects than conventional anti cancer drugs.
Version history
Last update:
‎07-28-2015 01:30 AM
Updated by: